Sysmex Europe
Menu
Sysmex Europe Company News and Events Press releases Japan’s First Automated Hematology…

Japan’s First Automated Hematology Analyzer Registered by the National Museum of Nature and Science as “Essential Historical Material for Science and Technology”

-Using Unique Technology to Cultivate True Automation in Blood Cell Counting-

Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) announces that the CC-1001 automated hematology analyzer, which the Company developed as Japan’s first instrument for automatically measuring the number of red and white blood cells, has been registered by Japan’s National Museum of Nature and Science (Director General: Yoshihiro Hayashi) as “Essential Historical Material for Science and Technology”, also known colloquially as “MIRAI Technology Heritage.”

 

The CC-1001 was cited for its application of world-first creative technology to cultivate true automation in blood cell counting through the development of a sophisticated hematology analyzer, and its conspicuous role in the development of today’s dynamic growth in the field of clinical testing.

 

A ceremony for receiving the registration card and commemorative shield will be held on Tuesday, September 10, at the National Museum of Nature and Science.

Read the full article

 

 

References

Back to overview
Copyright © Sysmex Europe GmbH. All rights reserved.

Cookie-Settings

We use cookies to enable you to optimally use our website and to improve our communication with you. We shall take your selection into account and use only the data for which you give us your consent.

These cookies help to make our website usable by enabling basic features such as page navigation and access to secure areas of our website. Our website cannot function properly without these cookies.

By collecting information anonymously, these cookies help us to understand how visitors interact with our website. This information enables us to continually improve our platform.

are used to track visitors on websites. The intention is to show advertisements that are relevant and appealing to the individual user and are, therefore, valuable to publishers and third-party advertisers.